Part 2 of 2 — the body's slower, targeted, learning defence
Where the innate immune system reacts to broad categories of danger within minutes using a fixed set of detectors, adaptive immunity builds a response tailored to one specific pathogen — and then remembers it, sometimes for life. The trade-off for that precision is speed: a first encounter with a new pathogen typically takes a week or more for the adaptive system to mount a full response, which is why the innate system's rapid holding action, covered in the companion guide, matters so much in the meantime. Adaptive immunity runs on two cooperating branches — the humoral response, run by B cells and the antibodies they produce, and the cell-mediated response, run by T cells — both built around cells called lymphocytes.
Both major cell types of adaptive immunity are lymphocytes, a class of white blood cell, and both originate from the same stem cells in bone marrow. From there, their paths diverge: B cells mature in the bone marrow itself (the "B" originally referred to the Bursa of Fabricius, an organ found in birds where the equivalent cells were first identified), while T cells migrate to the thymus, a gland behind the sternum, to complete their development — the source of the "T."
| Cell type | Matures in | Core job |
|---|---|---|
| B cells | Bone marrow | Produce antibodies (humoral response) |
| Helper T cells (CD4+) | Thymus | Coordinate and amplify the wider immune response |
| Cytotoxic T cells (CD8+) | Thymus | Directly kill infected or cancerous cells |
| Regulatory T cells | Thymus | Suppress the response once a threat is cleared, limit autoimmunity |
Lymphocytes can't directly inspect the inside of other cells, so the body uses a dedicated display system to show them what's happening internally. Nearly every nucleated cell in the body constantly loads small fragments of its own internal proteins onto a surface marker called MHC class I, presenting a running sample of its internal contents to the outside world. If a cell is infected by a virus, some of those fragments will be viral rather than the body's own, and passing cytotoxic T cells that recognise the fragment as foreign can identify the cell as infected and destroy it — a specific, targeted version of the surveillance NK cells perform non-specifically, described in the innate immunity guide.
A second, more selective marker, MHC class II, is displayed only by dedicated antigen-presenting cells — chiefly dendritic cells, macrophages, and B cells themselves — which display fragments of material they've actively engulfed from outside the cell, such as captured bacteria. Helper T cells check specifically for MHC class II, which is why they respond to threats the body has taken in and processed, rather than to what's happening inside a given cell directly.
Often considered the coordinators of the entire adaptive response, helper T cells don't kill anything directly. Once activated by an antigen-presenting cell, they release cytokines that amplify nearly every other part of the response — spurring B cells to multiply and produce antibodies, boosting cytotoxic T cells' killing activity, and recruiting more innate immune cells to the site. Their central role is precisely why they're such a consequential target: HIV infects and gradually destroys helper T cells specifically, which is what leaves the body unable to mount an effective response to infections it would otherwise handle easily.
Cytotoxic T cells patrol the body checking the MHC class I fragments displayed by ordinary cells, and destroy any cell presenting a fragment they recognise as foreign — chiefly virus-infected cells, and cells that have become cancerous. On finding a match, a cytotoxic T cell injects proteins that trigger the target cell to undergo a controlled, contained self-destruction (apoptosis), destroying the threat without rupturing the cell and spilling its contents into surrounding tissue.
An immune response strong enough to clear an infection can also cause serious collateral damage if it doesn't switch off. Regulatory T cells actively suppress other immune cells once a threat has passed, and are also central to self-tolerance — restraining any stray immune cells that might otherwise react against the body's own healthy tissue.
Each B cell carries a unique receptor on its surface that can bind one particular molecular shape, called an antigen. When a B cell's receptor binds a matching antigen — and, for most responses, receives a confirming signal from a helper T cell — it activates, multiplies rapidly, and differentiates into two cell types: short-lived plasma cells, which become dedicated antibody factories capable of secreting thousands of antibody molecules per second, and long-lived memory B cells, covered further below.
An antibody (also called an immunoglobulin) is a Y-shaped protein with two functional ends: the tips of the "Y" are a highly variable region that binds a specific antigen, while the base is a constant region that recruits other parts of the immune system — flagging the target for phagocytes, triggering the complement cascade, or neutralising a pathogen directly by physically blocking the part it needs to infect a cell.
| Class | Where it's found | Main role |
|---|---|---|
| IgG | Blood, tissue fluid | The most abundant class; provides long-term protection and crosses the placenta to protect newborns |
| IgM | Blood | First antibody produced in a new response; effective at activating complement |
| IgA | Mucus, saliva, breast milk | Protects mucosal surfaces and is passed to infants through breastfeeding |
| IgE | Tissue, bound to mast cells | Defends against parasites; also the main driver of allergic reactions |
| IgD | B cell surface | Functions mainly as a B cell receptor rather than a secreted antibody |
The body doesn't design a lymphocyte for each new pathogen as it appears — it generates an enormous, random library of lymphocytes in advance, each with a distinct antigen receptor, through a genetic shuffling process called V(D)J recombination that can produce well over a trillion possible receptor combinations. At any given moment, only a handful of circulating lymphocytes happen to carry a receptor that matches a given new pathogen.
When one of those rare matching lymphocytes does encounter its antigen, it's triggered to divide rapidly, producing a large population of identical cells — a clone — all bearing that same effective receptor. This process, clonal selection, is the reason a first response takes so long to build: the immune system effectively has to find the few right cells out of an enormous pool and then wait for them to multiply into a force large enough to matter, typically over one to two weeks.
Not every cell produced during clonal expansion is needed to fight off the current infection. A portion become long-lived memory B cells and memory T cells, which persist quietly for years or decades after the original threat is gone, without needing continual re-exposure to survive.
| Primary response (first exposure) | Secondary response (re-exposure) | |
|---|---|---|
| Lag before response | ~1-2 weeks | Hours to ~2-3 days |
| Peak antibody level | Moderate | Much higher |
| Dominant antibody class | IgM early, then IgG | IgG, rapidly |
| Clinical result | Full symptomatic illness | Often mild or entirely unnoticed |
Because memory cells already exist in large numbers and don't need to be found and expanded from scratch, a second encounter with the same pathogen is met with a faster, larger, and more effective response — usually fast enough to clear the pathogen before it causes noticeable illness at all. This is the entire biological basis of naturally acquired immunity after an infection.
A vaccine deliberately exploits immunological memory: it exposes the adaptive immune system to a safe, non-disease-causing version of a pathogen's antigens — a weakened live pathogen, an inactivated one, an isolated fragment of its structure, or, in newer mRNA vaccines, genetic instructions that let the body's own cells briefly manufacture just one harmless viral protein — enough to trigger clonal selection and generate memory cells, without ever causing the actual disease. If the real pathogen is encountered later, the immune system responds as though it were already a second exposure.
Because the lymphocyte library is generated largely at random, some of the receptors produced inevitably end up recognising the body's own healthy tissue rather than a foreign threat. Under normal conditions, most of these self-reactive lymphocytes are identified and eliminated during development in the thymus, a filtering process called negative selection, with regulatory T cells providing a second layer of suppression for any that slip through. When this tolerance fails, the result is autoimmune disease — the adaptive system mounting a genuine, targeted attack against the body's own cells. Type 1 diabetes, covered in our guide to diabetes and insulin, is a direct example: cytotoxic T cells and antibodies mistakenly target the pancreas's own insulin-producing beta cells for destruction, using exactly the same targeting machinery this guide describes being used against real pathogens.
This document provides a general scientific overview of the adaptive immune system for educational purposes, and is not medical advice.